Replies to post #299731 on Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

Leo should use Remde plus standard of care in both moderate and severe cv19 patients for the controlled group.

For critically ill patients, it will be Bril plus standard of care vs standard of care alone.

Mild is a gimme.

Big Pharma will be salivating once the lung in-vivo assay comes out. That's GOING TO BE GREAT AND THAT I CAN GUARANTEE TO YOU ALL! Imagine Bril working in and saving people's lives in severely and critically ill patients with ARDS?! Wow!!

My gold standard? Leaving no stone unturned even if IPIX was listed on OTC. Bril has up to $10b clinical application potential, imo. I'm in at 7, 9,... Thank you!

GB

[MXAMDUD]

All conjecture. And misleading at that. Loe has been saying 'patrnership for 5+ years and nothing. no money. just dilution and treating shareholders like a home equity loan. He buries bad news on late Fridays - I fully expect him to pull another P. BP is well aware of B and has never given him a dime. We sit at .17 rotting away.

[LilyGDog]

100% agree! Leo can do this.

Go Leo & IPIX!

The gold standard means government and/or grant funding are coming our way. Oh, who is to say that Leo doesn't have a private placement funding lined up already to fund Phase II trial in mild, moderate, severe, and critically ill patients if there's a delay in funding? That's not counting a bp partnership or acquisition after the lung in vivo assay! YIKES!

He's no dummy when it comes to securing funding with Bril being the best THERAPEUTIC AND PROPHYLAXIS COMPOUND THERE IS IN COMBATING SARsCoV2! Oh, man! This company will trade over $500m in no time.

Checkmate! Bril is a BLOCKBUSTER DRUG FOR COVID.